This paper aims at delivering a structured overview of telerehabilitation literature by analysing the entire set of articles under the search terms "telerehabilitation" or "tele-rehabilitation" to portray "state of the art" ten years after the publication of the first scientific article on the topic. A structured study has been conducted by considering all those articles containing the word "telerehabilitation" or "telerehabilitation". Medline, Embase, Cochrane, UK Centre for Reviews and Dissemination, Canadian Agency for Drugs and Technologies in Health databases have been interrogated for articles between 1998 and 2008. 146 scientific articles were found. 56 articles focus on patient treatment, 23 are reviews, 3 are to be considered as both patient treatment papers and reviews, 53 are either technical reports, system descriptions or analyses of new approaches; 8 are general discussion on telerehabilitation. The present paper draw the scenario of the first ten years of telerehabilitation, focussing on clinical applications and technologies. Basically, it confirms the lack of comprehensive studies providing evidence for supporting decision and policy-makers in adopting telerehabilitation technologies in the clinical practice. An overall lack of standardisation in the used terminology also results from the analysis of keywords, which is typical of quite recent fields of application.

Objectives ASD is a lifelong multifaceted condition with considerable impact and costs to the single patients, their family and wider society, hence emphasizing the need of tailoring services for ASD subjects and their families. In Italy, recent efforts have been made to harmonize and promote the appropriateness of interventions for ASD people. At present, scattered information on services for people with ASD is available. The aim of this study was to survey the presence and distribution of child and adolescent mental health services (CAMHs) in Italy, devoting a specific focus on their capacity to provide care to ASD patients. Methods CAMHs based on local health services, public and university hospitals, and care/research institutions, as well as private (INHS-accredited) units were invited to participate to present investigation filling in a questionnaire assessing relevant dimensions for public health, namely overall structural capacity and ASD care processes. Results Heterogeneity of the results among geographical macro-areas in CAMHs provision was found. Specifically, for ASD care, diagnosis and intervention strategies resulted to be unevenly distributed across the Italian territory, and the level of service integration throughout transition into adulthood resulted to be low. Conclusions Results from this survey contribute to increase the knowledge on services provided in Italy to people with ASD, and suggest potential targets to improve ASD management. The final aim is to ensure that the conditions are in place to achieve the adequate capacity to respond to the needs of individuals affected and their families over time and across the whole country. Keywords Autism spectrum disorders. Child-adolescent mental health services. Systems of care. Italy Based on national and international estimate of prevalence (Elsabbagh et al. 2012; Narzisi et al. 2018), there are about 600,000 people with Autism Spectrum Disorders (ASD) in Italy, including about 100,000 under the age of 18 years. ASD is a lifelong condition with considerable impact and costs to the individuals, their family, and wider society (Howlin et al. 2013). Direct and indirect (e.g., individual and parental productivity loss), as well as lifetime social economic costs, have been associated with ASD (Buescher et al. 2014). Families of children with autism face higher levels of distress than those of children with other disabilities: psychological disorders are common in the caregivers and appear to be marked with high levels of stress, anxiety, and depression (Lai et al. 2015; Picardi

Background. Cancer patients are among the main consumers of traditional, complementary, integrative, and alternative medicine (TCIM) such as natural products (herbals, integrators, etc.) and mind and body practices (yoga, acupuncture, etc.). Methods. A questionnaire on TCIM was submitted to 415 Italian cancer patients. The questionnaire consisted of three sections: (i) biographical and clinical information; (ii) use of natural substances; and (iii) use of mind-body practices. Results. 406 patients completed the questionnaire. The prevalence of TCIM use was 72.3%. Of them, 75.6% started to use TCIM after a tumor diagnosis. The main reasons for using TCIM were to mitigate side effects (65.0%), to regain physical and mental balance (35.9%), to relieve pain (18.3%), and to improve the efficacy of cancer therapy (16.0%). 44.7% of patients taking natural products used them during conventional therapies (chemotherapy, radiotherapy, etc.), and in 67.5% of cases without consulting a doctor. As a consequence, only about 50% of patients taking natural substances used these compounds appropriately, and the most common errors were related with the purpose of reducing the side effects of the therapy (52.3%) and for boosting immune system (32.1%). Conclusions. There is an impelling need to provide patients with scientifically validated information to raise awareness about the benefits and risks of using TCIM.

No abstract

No abstract